XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt signalling pathway

Figure 5 Knock-down of XB130 accelerated wound healing in diabetic mice. A: Western blot analysis of XB130 protein expression in each group; B: Quantification of Western blot results; C: Representative skin wound images from control and model mice at day 0 d, 7 d, 14 d, control (n = 10), model (n = 10), Vector (n = 10), and XB130-KD (n = 10); D: HE and Masson staining of skin wound in each group. ^aP < 0.001, compared to the Control group; ^bP < 0.01, compared to the Vector group.